• Je něco špatně v tomto záznamu ?

Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport?

Václavíková R, Boumendjel A, Ehrlichová M, Kovár J, Gut I.

. 2006 ; 14 (13) : 4519-4525.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc07523708

Grantová podpora
NL7567 MZ0 CEP - Centrální evidence projektů

We have investigated the effect of 13 flavonoid derivatives on [(14)C]paclitaxel transport in two human breast cancer cell lines, the adriamycin-resistant NCI/ADR-RES and sensitive MDA-MB-435. For this study, we selected representatives of aurones, chalcones, flavones, flavonols, chromones, and isoflavones with known binding affinity toward nucleotide-binding domain (NBD2) of P-glycoprotein and for which no reported work is available regarding paclitaxel transport. Aurones CB-284, CB-285, CB-287, and ML-50 most effectively inhibited P-gp related transport in the resistant line in comparison with chalcones, flavones, flavonols, chromones, and isoflavone derivatives and accordingly increased the accumulation of [(14)C]paclitaxel and decreased its efflux. Those agents efficiently modulated paclitaxel transport in P-gp highly expressing resistant human breast cancer cells and they could increase the efficiency of chemotherapy in paclitaxel-resistant tumors. In contrast, the sensitive cell line responded reversely in that CB-284, CB-285, CB-287, and ML-50 significantly inhibited accumulation of [(14)C]paclitaxel and especially CB-287, which significantly stimulated its efflux. Some, but not all, of the data correlated with the binding of flavonoid derivatives to P-gp, and indicated that even in the P-gp highly expressing NCI/ADR-RES cells, the binding was not the only factor influencing the transport of [(14)C]paclitaxel. Opposite effects of flavonoid derivatives on the P-gp highly expressing and MDA-MB-435 non-expressing cell lines indicate that paclitaxel is not only transported by P-gp and let us assume that Mrp2 or ABCC5 seem to be good transport-candidates in these cells. The inhibition of paclitaxel accumulation and stimulation of its efflux are potentially unfavorable for drug therapy and since they could be due to modulation of drug transporters other than P-gp, their expression in tumors is of great significance for efficient chemotherapy.

000      
00000naa 2200000 a 4500
001      
bmc07523708
003      
CZ-PrNML
005      
20130530113326.0
008      
090524s2006 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Václavíková, Radka $7 xx0142918
245    10
$a Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport? / $c Václavíková R, Boumendjel A, Ehrlichová M, Kovár J, Gut I.
314    __
$a Biotransformation Group, National Institute of Public Health, Praha, Czech Republic. rvaclavikova@szu.cz
520    9_
$a We have investigated the effect of 13 flavonoid derivatives on [(14)C]paclitaxel transport in two human breast cancer cell lines, the adriamycin-resistant NCI/ADR-RES and sensitive MDA-MB-435. For this study, we selected representatives of aurones, chalcones, flavones, flavonols, chromones, and isoflavones with known binding affinity toward nucleotide-binding domain (NBD2) of P-glycoprotein and for which no reported work is available regarding paclitaxel transport. Aurones CB-284, CB-285, CB-287, and ML-50 most effectively inhibited P-gp related transport in the resistant line in comparison with chalcones, flavones, flavonols, chromones, and isoflavone derivatives and accordingly increased the accumulation of [(14)C]paclitaxel and decreased its efflux. Those agents efficiently modulated paclitaxel transport in P-gp highly expressing resistant human breast cancer cells and they could increase the efficiency of chemotherapy in paclitaxel-resistant tumors. In contrast, the sensitive cell line responded reversely in that CB-284, CB-285, CB-287, and ML-50 significantly inhibited accumulation of [(14)C]paclitaxel and especially CB-287, which significantly stimulated its efflux. Some, but not all, of the data correlated with the binding of flavonoid derivatives to P-gp, and indicated that even in the P-gp highly expressing NCI/ADR-RES cells, the binding was not the only factor influencing the transport of [(14)C]paclitaxel. Opposite effects of flavonoid derivatives on the P-gp highly expressing and MDA-MB-435 non-expressing cell lines indicate that paclitaxel is not only transported by P-gp and let us assume that Mrp2 or ABCC5 seem to be good transport-candidates in these cells. The inhibition of paclitaxel accumulation and stimulation of its efflux are potentially unfavorable for drug therapy and since they could be due to modulation of drug transporters other than P-gp, their expression in tumors is of great significance for efficient chemotherapy.
650    _2
$a antitumorózní látky fytogenní $x metabolismus $7 D000972
650    _2
$a biologický transport $x účinky léků $7 D001692
650    _2
$a nádory prsu $x metabolismus $7 D001943
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a flavonoidy $x farmakologie $x chemie $7 D005419
650    _2
$a lidé $7 D006801
650    _2
$a P-glykoprotein $x metabolismus $x účinky léků $7 D020168
650    _2
$a paclitaxel $x metabolismus $7 D017239
650    _2
$a terciární struktura proteinů $x účinky záření $7 D017434
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a financování organizované $7 D005381
700    1_
$a Boumendjel, Ahcene
700    1_
$a Ehrlichová, Marie $7 xx0067467
700    1_
$a Kovář, Jan, $d 1952- $7 jn20040114001
700    1_
$a Gut, Ivan, $d 1936- $7 xx0060370
773    0_
$w MED00000769 $t Bioorganic & medicinal chemistry $g Roč. 14, č. 13 (2006), s. 4519-4525 $x 0968-0896
910    __
$a ABA008 $b x $y 9
990    __
$a 20090506084234 $b ABA008
991    __
$a 20130530113657 $b ABA008
999    __
$a ok $b bmc $g 656783 $s 510102
BAS    __
$a 3
BMC    __
$a 2006 $b 14 $c 13 $d 4519-4525 $i 0968-0896 $m Bioorganic & medicinal chemistry $x MED00000769
GRA    __
$a NL7567 $p MZ0
LZP    __
$a 2009-B2/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...